Insulet (PODD) reported $543.9 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 25.7%. EPS of $0.90 for the same period compares to $0.71 a year ago.

Insulet Corporation posted a strong set of Q2 financials, growing sales at a historical run rate of 30%. Despite a sharp decline in PODD's market value, findings don't recommend buying the stock as ...

PODD exhibits bullish price action with a series of higher highs and lows, trading above its upward sloping 30-week EMA since August 2024. Momentum is long-term bullish but short-term bearish, with ...